Prostate Cancer
Showing NaN - NaN of 175
Mechanisms of Resistance to PSMA Radioligand Therapy
Recruiting
- Prostate Cancer
- Single-photon emission computed tomography
- +2 more
-
Los Angeles, California
- +2 more
Jun 22, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
-
Gilbert, Arizona
- +4 more
Jun 21, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)
Active, not recruiting
- Cushing's Disease
- +8 more
-
La Jolla, California
- +93 more
May 19, 2022
Prostate Cancer Trial in United States (177Lu-J591, Ketoconazole, Hydrocortisone)
Active, not recruiting
- Prostate Cancer
- 177Lu-J591
- +3 more
-
Los Angeles, California
- +8 more
Mar 25, 2022
Prostate Cancer Trial in Canada, United States (Radiation Therapy, Enzalutamide, Bicalutamide)
Recruiting
- Prostate Cancer
- Radiation Therapy
- +3 more
-
Gilbert, Arizona
- +107 more
Mar 17, 2022
Prostate Cancer Trial in Worldwide (rhPSMA-7.3 (18F) Injection)
Completed
- Prostate Cancer
- rhPSMA-7.3 (18F) Injection
-
Birmingham, Alabama
- +33 more
Mar 15, 2022
Prostate Cancer Trial in Finland, Netherlands, United States (rhPSMA-7.3 (18F) Injection)
Completed
- Prostate Cancer
- rhPSMA-7.3 (18F) Injection
-
Birmingham, Alabama
- +27 more
Mar 15, 2022
Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Cancer of the Prostate Trial in Worldwide (Enzalutamide,
Active, not recruiting
- Nonmetastatic Castration-Resistant Prostate Cancer
- +2 more
- Enzalutamide
- Placebo
-
Tucson, Arizona
- +396 more
Feb 22, 2022
Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- TALZENNA capsule
- Talazoparib soft gel capsule
-
Encinitas, California
- +31 more
Feb 14, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
Enrolling by invitation
- Prostate Cancer
- +2 more
- Hemigland Cryoablation
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Jan 25, 2022
Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Elly Mobile Phone Application)
Recruiting
- Cancer
- +22 more
- Elly Mobile Phone Application
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 7, 2021
Prostate Cancer Trial in United States (Zytiga® (Abiraterone Acetate), SoluMatrix™ (Abiraterone Acetate))
Completed
- Prostate Cancer
- Zytiga® (Abiraterone Acetate)
- SoluMatrix™ (Abiraterone Acetate)
-
Laguna Hills, California
- +16 more
Nov 19, 2021
Prostate Cancer Trial in Canada, United States (Enzalutamide, Active Surveillance)
Completed
- Prostate Cancer
- Enzalutamide
- Active Surveillance
-
Birmingham, Alabama
- +53 more
Oct 14, 2021
Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)
Completed
- Metastatic Cancer
- Prostate Cancer
- atrasentan hydrochloride
- +3 more
-
Mobile, Alabama
- +553 more
Oct 8, 2021
Radiologically Guided Biopsies of mCRPC
Completed
- Prostate Cancer
- Image-Guided Biopsies
-
Davis, California
- +4 more
Sep 30, 2021
HIFU for Focal Ablation of Prostate Tissue: An Observational
Enrolling by invitation
- Prostate Cancer
- Sonablate HIFU device
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Sep 27, 2021
Digitally Captured Activity Data and PROs to Monitor Physical
Recruiting
- Prostate Cancer
- Wearable Activity Monitor
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jul 27, 2021
Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)
Prostate Cancer Trial in Los Angeles (Positron Emission Tomography (PET) Imaging)
Approved for marketing
- Prostate Cancer
- Positron Emission Tomography (PET) Imaging
-
Los Angeles, CaliforniaUniversity of California at Los Angeles
Jun 21, 2021
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Recurrent Trial in Canada, United States (18F-DCFPyL, PET/CT Imaging)
Completed
- Prostate Cancer
- +3 more
- 18F-DCFPyL
- PET/CT Imaging
-
Duarte, California
- +13 more
Jun 10, 2021